Fosgonimeton

DB21516InvestigationalSmall molecule

Fosgonimeton is a small molecule drug. Fosgonimeton is under investigation in clinical trial NCT05511558 (A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)). Fosgonimeton has a monoisotopic molecular...

Mechanism: Pharmacologically active on Hepatocyte growth factor receptor and Hepatocyte growth factor
Curator reviewed
Formula / weight: C₂₇H₄₅N₄O₈P · 584.651 g/mol (avg)
Code names: ATH-1017 FREE ACID · NDX-1017 FREE ACID

Resolves to

Compound

UNIIH91OA9858JCAS2093305-05-4ChEMBLCHEMBL5095419

Structure

InChIKeyMBYDCPOKVKDSFD-JTJYXVOQSA-NSMILESCCCCCC(=O)N[C@@H](CC1=CC=C(OP(O)(O)=O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCCCCCC(N)=O

Targets

P08581METP14210HGF

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fosgonimeton, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account